MEDICREA® Hosts Third Annual User Group Meeting (MAIA) in Lyon, France Followed by Attendance at SRS in Montreal, Canada
26 Septembre 2019 - 06:48PM
Business Wire
The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED
; OTCQX Best Market – MRNTF), pioneering the digital transformation
of spinal surgery through Artificial Intelligence, predictive
modeling and patient specific implants with its UNiD™ ASI (Adaptive
Spine Intelligence) proprietary software platform, services and
technologies, announced today that it hosted the third edition of
its annual MEDICREA® Artificial Intelligence and Analytics (MAIA)
meeting in Lyon, France from September 12-14, and continued their
conversations at the 54th annual meeting & course hosted by SRS
(Scoliosis Research Society) in Montreal, Canada.
The MAIA meeting continues to be the first of its kind, an
ongoing collaboration between surgeons and industry to focus on the
role of Artificial Intelligence in the treatment of complex spinal
deformities and degenerative indications. During this third annual
meeting, surgeons and the company discussed the next transformative
advances in spinal surgery as well as their role working in tandem
with UNiD™ ASI (Adaptive Spine Intelligence) technology and expert
services.
Prior to attending SRS (Spine Research Society), MEDICREA®
concluded a successful MAIA User Group Meeting at its headquarters
in Lyon, France. MAIA was attended by fifteen of the leading spine
surgeons including co-chairs Dr Chris Ames, MD, Director of spinal
tumor and spinal deformity surgery at UCSF Medical Center, CA, Dr
Vedat Deviren, MD, Professor of Orthopedic Surgery at the UCSF
Spine Center, CA; Dr Evalina Burger, MD, Professor and Chair of
Orthopedics at the University of Colorado, Dr Christopher Kleck,
MD, Assistant Professor, Associate Program Director, Co-Director
Spine Fellowship at UC Denver, CO and Dr Rajiv Sethi, MD, Executive
Director and Chair of the Neuroscience Institute, Departments of
Orthopaedics and Neurosurgery, Virginia Mason Medical Center,
WA.
Dr Chris Ames, MD, stated of his discussion at MAIA, “The next
disruptive advance in spinal surgery will not go inside the patient
as an implant. It will be a chimera. The augmentation of surgeon
intelligence with AI. We will see our patients’ futures prior to
surgery.”
During this third edition, MEDICREA® also demonstrated the
advancements made to its proprietary UNiD™ ASI (Adaptive Spine
Intelligence) technology. Through the deployment & enhancement
of predictive models based on 3D analysis of medical images, and
the interactive access to patients’ analytics through the UNiD™
Hub, MEDICREA® works with its surgeon partners to iteratively
improve patient’s outcomes. The UNiD™ ASI pre-operative surgical
planning tool and its associated expert concierge services provide
surgeons with accurate patient-specific implantable devices and
help streamlining implant inventory in the operating room. To date,
more than 4,500 patients have benefited from this unique
technology.
MEDICREA® is excited to pursue its UNiD™ ASI development efforts
with these leading surgeons. The company’s current predictive model
uses a wide-array of patient-specific data to predict compensatory
mechanisms that are most likely to occur above and below the
instrumented portion of the spine. Following conversations with its
surgeon partners, the company is permanently improving its existing
models by including more patient-specific parameters with the end
goal to provide more A.I.-based outcome simulations and prediction
of a surgery success.
Denys Sournac, Chief Executive Officer of MEDICREA®, to conclude
“Since 2013, MEDICREA® has been pioneering and leading the
A.I.-based solutions dedicated to spine surgery. With the help of
its surgeon partners, the company is strengthening its platform to
maintain its competitive advantage and provide surgeons with
improved solutions to make more informed decisions with the end
goal of always improving patient-outcomes.”
About MEDICREA® (www.medicrea.com)
Through the lens of predictive medicine, MEDICREA® leverages its
proprietary software analysis tools with big data and machine
learning technologies supported by an expansive collection of
clinical and scientific data. The Company is well-placed to
streamline the efficiency of spinal care, reduce procedural
complications and limit time spent in the operating room.
Operating in a $10 billion marketplace, MEDICREA® is a Small and
Medium sized Enterprise (SME) with 180 employees worldwide, which
includes 40 who are based in the U.S. The Company has an
ultra-modern manufacturing facility in Lyon, France housing the
development and production of 3D- printed titanium patient-specific
implants.
For further information, please visit:
medicrea.com.
Connect with MEDICREA® FACEBOOK |
INSTAGRAM | TWITTER | WEBSITE | YOUTUBE
MEDICREA® is listed on EURONEXT Growth Paris
ISIN: FR 0004178572 Ticker: ALMED LEI: 969500BR1CPTYMTJBA37
MEDICREA® is traded on OTCQX Best Market
Tickers: MRNTF
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190926005713/en/
MEDICREA® Denys SOURNAC Founder, Chairman and CEO
dsournac@medicrea.com
Fabrice KILFIGER Chief Financial Officer
fkilfiger@medircrea.com
Tel: +33 (0)4 72 01 87 87